Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu

Jonathan W. Friedberg, M.D., M.M.Sc.

Publications

Showing all 261 journal articles & 26 books available

Journal Articles

11/25/2020
de Vos S, Leonard JP, Friedberg JW, Zain J, Dunleavy K, Humerickhouse R, Hayslip J, Pesko J, Wilson WH. "Safety and efficacy of navitoclax, a BCL-2 and BCL-X inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study." Leukemia & lymphoma.. 2020 Nov 25; :1-9. Epub 2020 Nov 25.

10/30/2020
Zent CS, Brady MT, Delage C, Strawderman M, Laniewski N, Contant PN, Kanagaiah P, Sangster MY, Barr PM, Chu CC, Topham DJ, Friedberg JW. "Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma." Leukemia.. 2020 Oct 30; Epub 2020 Oct 30.

10/26/2020
Persky DO, Smith SM, LeBlanc ML, Friedberg JW. "Reply to E. Hawkes et al." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 Oct 26; :JCO2002856. Epub 2020 Oct 26.

10/25/2020
Rodgers TD, Williams AM, Baran A, Reagan PM, Casulo C, Zent CS, Evans A, Friedberg JW, Barr PM. "Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma." Leukemia & lymphoma.. 2020 Oct 25; :1-8. Epub 2020 Oct 25.

10/2020
Rodgers TD, Friedberg JW. "Key Clinical and Translational Research Questions to Address Unmet Needs in Mantle Cell Lymphoma." Hematology/oncology clinics of North America.. 2020 Oct 0; 34(5):983-996. Epub 2020 Aug 05.

8/2020
Friedberg JW. "Toward a Cure for Follicular Lymphoma." Hematology/oncology clinics of North America.. 2020 Aug 0; 34(4):xiii-xiv. Epub 2020 May 20.

8/2020
Friedberg JW. "Optimizing the Use of Oral Therapy in Lymphoma." Clinical advances in hematology & oncology : H&O.. 2020 Aug 0; 18(8):454-456.

7/13/2020
Persky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ, Barr PM, Winegarden JD, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, LeBlanc ML, Song JY, Fisher RI, Rimsza LM, Smith SM, Miller TP, Friedberg JW. "Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 Jul 13; :JCO2000999. Epub 2020 Jul 13.

5/26/2020
Ha CS, LeBlanc M, Schöder H, Pinnix CC, Bartlett NL, Evens AM, Hsi ED, Rimsza L, Knopp MV, Zhang J, Leonard JP, Kahl BS, Li H, Smith S, Constine LS, Friedberg JW. "Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816." Leukemia & lymphoma.. 2020 May 26; :1-6. Epub 2020 May 26.

5/26/2020
Roschewski M, Dunleavy K, Abramson JS, Powell BL, Link BK, Patel P, Bierman PJ, Jagadeesh D, Mitsuyasu RT, Peace D, Watson PR, Hanna WT, Melani C, Lucas AN, Steinberg SM, Pittaluga S, Jaffe ES, Friedberg JW, Kahl BS, Little RF, Bartlett NL, Fanale MA, Noy A, Wilson WH. "Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 May 26; :JCO2000303. Epub 2020 May 26.

3/13/2020
Schöder H, Polley MY, Knopp MV, Hall NC, Kostakoglu L, Zhang J, Higley HR, Kelloff G, Liu H, Zelenetz A, Cheson BD, Wagner-Johnston ND, Kahl B, Friedberg JW, Hsi ED, Leonard JP, Schwartz LH, Wilson WH, Bartlett NL. "Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial." Blood.. 2020 Mar 13; Epub 2020 Mar 13.

2/23/2020
Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK. "First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based study." British journal of haematology.. 2020 Feb 23; Epub 2020 Feb 23.

12/17/2019
Rodgers TD, Baran A, Reagan PM, Casulo C, Zent C, Evans A, Burack R, Williams AM, Friedberg JW, Barr PM. "Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma." British journal of haematology.. 2019 Dec 17; Epub 2019 Dec 17.

10/22/2019
Kamdar M, Li H, Chen RW, Rimsza LM, Leblanc ML, Fenske TS, Shea TC, Barr PM, Phillips TJ, Leonard JP, Kahl BS, Friedberg JW, Smith SM. "Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma." Blood advances.. 2019 Oct 22; 3(20):3132-3135.

10/2019
Zackon AYL, Ayers AA, Yeager KA, Somma ML, Friedberg JW, Flowers CR, Nastoupil LJ. "Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs." Leukemia & lymphoma.. 2019 Oct 0; 60(10):2356-2364. Epub 2019 Jun 04.

7/22/2019
Stephens DM, Li H, Schöder H, Straus DJ, Moskowitz CH, Leblanc M, Rimsza LM, Bartlett NL, Evens AM, LaCasce AS, Barr PM, Knopp MV, Hsi E, Leonard JP, Kahl B, Smith SM, Friedberg JW. "." Blood.. 2019 Jul 22; Epub 2019 Jul 22.

7/20/2019
Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, Leonard JP. "Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2019 Jul 20; 37(21):1790-1799. Epub 2019 Apr 02.

7/8/2019
Loh KP, Baran A, Lee CY, Alshaibani A, Rutherford SC, Hu J, Casulo C, Barr PM, Friedberg JW, Reagan PM. "Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation." Leukemia & lymphoma.. 2019 Jul 8; :1-4. Epub 2019 Jul 08.

5/1/2019
Kanate AS, Kumar A, Dreger P, Dreyling M, Le Gouill S, Corradini P, Bredeson C, Fenske TS, Smith SM, Sureda A, Moskowitz A, Friedberg JW, Inwards DJ, Herrera AF, Kharfan-Dabaja MA, Reddy N, Montoto S, Robinson SP, Abutalib SA, Gisselbrecht C, Vose J, Gopal A, Shadman M, Perales MA, Carpenter P, Savani BN, Hamadani M. "Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT." JAMA oncology.. 2019 May 1; 5(5):715-722.

3/15/2019
Ramchandren R, Advani RH, Ansell SM, Bartlett NL, Chen R, Connors JM, Feldman T, Forero-Torres A, Friedberg JW, Gopal AK, Gordon LI, Kuruvilla J, Savage KJ, Younes A, Engley G, Manley TJ, Fenton K, Straus DJ. "Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2019 Mar 15; 25(6):1718-1726. Epub 2019 Jan 07.

2/14/2019
Loh KP, Dunne RF, Friedberg JW, Mohile SG. "Integrating Assessment of Sarcopenia into Decision-making for Allogeneic Hematopoietic Cell Transplantation: Ready for Prime Time?" Journal of the National Cancer Institute.. 2019 Feb 14; Epub 2019 Feb 14.

2/5/2019
Hsi ED, Li H, Nixon AB, Schöder H, Bartlett NL, LeBlanc M, Smith S, Kahl BS, Leonard JP, Evens AM, Scott DW, Rimsza LM, Friedberg JW. "Serum levels of TARC, MDC, IL10 and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study." Blood.. 2019 Feb 5; Epub 2019 Feb 05.

2/2019
Link BK, Day BM, Zhou X, Zelenetz AD, Dawson KL, Cerhan JR, Flowers CR, Friedberg JW. "Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study." British journal of haematology.. 2019 Feb 0; 184(4):660-663. Epub 2018 Apr 02.

1/10/2019
Al-Mansour Z, Li H, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, Smith SM, Marcellus DC, Barton KP, Mills GM, LeBlanc M, Rimsza LM, Forman SJ, Leonard JP, Fisher RI, Friedberg JW, Stiff PJ. "Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis." Leukemia & lymphoma.. 2019 Jan 10; :1-8. Epub 2019 Jan 10.

1/3/2019
Qu X, Li H, Braziel RM, Passerini V, Rimsza LM, Hsi ED, Leonard JP, Smith SM, Kridel R, Press O, Weigert O, LeBlanc M, Friedberg JW, Fang M. "Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016." Blood.. 2019 Jan 3; 133(1):81-93. Epub 2018 Nov 16.

12/15/2018
Kelly KR, Friedberg JW, Park SI, McDonagh K, Hayslip J, Persky D, Ruan J, Puvvada S, Rosen P, Iyer SP, Stefanovic A, Bernstein SH, Weitman S, Karnad A, Monohan G, VanderWalde A, Mena R, Schmelz M, Spier C, Groshen S, Venkatakrishnan K, Zhou X, Sheldon-Waniga E, Leonard EJ, Mahadevan D. "Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2018 Dec 15; 24(24):6150-6159. Epub 2018 Aug 06.

12/2018
Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH. "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study." The Lancet. Haematology.. 2018 Dec 0; 5(12):e609-e617.

10/13/2018
Williams AM, Baran AM, Casulo C, Reagan P, Friedberg JW, Helber M, Moore J, Baloga E, Zent CS, Barr PM. "Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience." Clinical lymphoma, myeloma & leukemia.. 2018 Oct 13; Epub 2018 Oct 13.

10/2018
Frank MJ, Reagan PM, Bartlett NL, Gordon LI, Friedberg JW, Czerwinski DK, Long SR, Hoppe RT, Janssen RS, Candia AF, Coffman RL, Levy R. "Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma." Cancer discovery.. 2018 Oct 0; 8(10):1258-1269. Epub 2018 Aug 28.

9/6/2018
Straus DJ, Jung SH, Pitcher B, Kostakoglu L, Grecula JC, Hsi ED, Schöder H, Popplewell LL, Chang JE, Moskowitz CH, Wagner-Johnston N, Leonard JP, Friedberg JW, Kahl BS, Cheson BD, Bartlett NL. "CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET." Blood.. 2018 Sep 6; 132(10):1013-1021. Epub 2018 Jul 26.

9/2018
Casulo C, Friedberg JW. "Burkitt lymphoma- a rare but challenging lymphoma." Best practice & research. Clinical haematology.. 2018 Sep 0; 31(3):279-284. Epub 2018 Jul 23.

8/29/2018
David RJ, Baran A, Loh KP, Casulo C, Barr PM, Friedberg JW, Reagan PM. "Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma." Clinical lymphoma, myeloma & leukemia.. 2018 Aug 29; Epub 2018 Aug 29.

8/10/2018
Friedberg JW. "Progress in Advanced-Stage Follicular Lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2018 Aug 10; 36(23):2363-2365. Epub 2018 Jun 01.

8/2018
Persky DO, Li H, Rimsza LM, Barr PM, Popplewell LL, Bane CL, Von Gehr A, LeBlanc M, Fisher RI, Smith SM, Friedberg JW. "A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806." American journal of hematology.. 2018 Aug 0; 93(4):486-493. Epub 2018 Jan 25.

6/2018
Casulo C, Friedberg JW, Ahn KW, Flowers C, DiGilio A, Smith SM, Ahmed S, Inwards D, Aljurf M, Chen AI, Choe H, Cohen J, Copelan E, Farooq U, Fenske TS, Freytes C, Gaballa S, Ganguly S, Jethava Y, Kamble RT, Kenkre VP, Lazarus H, Lazaryan A, Olsson RF, Rezvani AR, Rizzieri D, Seo S, Shah GL, Shah N, Solh M, Sureda A, William B, Cumpston A, Zelenetz AD, Link BK, Hamadani M. "Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2018 Jun 0; 24(6):1163-1171. Epub 2017 Dec 11.

4/2018
Smith EP, Li H, Friedberg JW, Constine LS, Rimsza LM, Cook JR, Laport GG, Popplewell LL, Holmberg LA, Smith SM, LeBlanc M, Forman SJ, Fisher RI, Stiff PJ. "Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2018 Apr 0; 24(4):700-707. Epub 2017 Dec 28.

4/2018
Rimsza LM, Li H, Braziel RM, Spier CM, Persky DO, Dunlap J, LeBlanc M, Bartlett N, Leonard JP, Smith SM, Press OW, Friedberg JW. "Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort." Haematologica.. 2018 Apr 0; 103(4):e151-e153. Epub 2018 Feb 22.

3/1/2018
Shadman M, Li H, Rimsza L, Leonard JP, Kaminski MS, Braziel RM, Spier CM, Gopal AK, Maloney DG, Cheson BD, Dakhil S, LeBlanc M, Smith SM, Fisher RI, Friedberg JW, Press OW. "Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2018 Mar 1; 36(7):697-703. Epub 2018 Jan 22.

3/2018
Barr PM, Li H, Burack WR, LeBlanc M, Smith SM, Gopal AK, Floyd JD, Persky DO, Press OW, Fisher RI, Friedberg JW. "R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study." The Lancet. Haematology.. 2018 Mar 0; 5(3):e102-e108. Epub 2018 Jan 26.

1/1/2018
Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM. "Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis." Cancer.. 2018 Jan 1; 124(1):136-144. Epub 2017 Sep 13.

12/28/2017
Friedberg JW, Forero-Torres A, Bordoni RE, Cline VJM, Patel Donnelly D, Flynn PJ, Olsen G, Chen R, Fong A, Wang Y, Yasenchak CA. "Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ?60 years with HL." Blood.. 2017 Dec 28; 130(26):2829-2837. Epub 2017 Oct 16.

12/28/2017
Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, Timmerman JM, Stiff PJ, Friedberg JW, Flinn IW, Goy A, Hill BT, Smith MR, Deol A, Farooq U, McSweeney P, Munoz J, Avivi I, Castro JE, Westin JR, Chavez JC, Ghobadi A, Komanduri KV, Levy R, Jacobsen ED, Witzig TE, Reagan P, Bot A, Rossi J, Navale L, Jiang Y, Aycock J, Elias M, Chang D, Wiezorek J, Go WY. "Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma." The New England journal of medicine.. 2017 Dec 28; 377(26):2531-2544. Epub 2017 Dec 10.

12/12/2017
Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, Sehn LH, Feldman T, Abramson JS, Kritharis A, Hernandez-Ilizaliturri FJ, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA, Jagadeesh D, Woda B, Gupta GK, Gascoyne RD, Jaffe ES, Evens AM. "Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL." Blood advances.. 2017 Dec 12; 1(26):2600-2609. Epub 2017 Dec 11.

12/2017
Gascoyne RD, Nadel B, Pasqualucci L, Fitzgibbon J, Payton JE, Melnick A, Weigert O, Tarte K, Gribben JG, Friedberg JW, Seymour JF, Cavalli F, Zucca E. "Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015." Hematological oncology.. 2017 Dec 0; 35(4):397-407. Epub 2017 Apr 04.

11/1/2017
Xi D, Bao T, Chen Q, Chen S, Cheng YC, Cullen J, Frank DA, Friedberg JW, Kronish I, Lee JE, Levine M, Li P, Li S, Lu W, Mao JJ, O'Keefe S, Rubinstein L, Shah MA, Standish L, Paller CJ, Chu E. "State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report." Journal of the National Cancer Institute. Monographs.. 2017 Nov 1; 2017(52)

11/2017
Kharfan-Dabaja MA, Kumar A, Ayala E, Hamadani M, Reimer P, Gisselbrecht C, d'Amore F, Jantunen E, Ishida T, Bazarbachi A, Foss F, Advani R, Fenske TS, Lazarus HM, Friedberg JW, Aljurf M, Sokol L, Tobinai K, Tse E, Burns LJ, Chavez JC, Reddy NM, Suzuki R, Ahmed S, Nademanee A, Mohty M, Gopal AK, Fanale MA, Pro B, Moskowitz AJ, Sureda A, Perales MA, Carpenter PA, Savani BN. "Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2017 Nov 0; 23(11):1826-1838. Epub 2017 Aug 07.

9/1/2017
Casulo C, Nastoupil L, Fowler NH, Friedberg JW, Flowers CR. "Unmet needs in the first-line treatment of follicular lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Sep 1; 28(9):2094-2106.

8/3/2017
Friedberg JW. "How I treat double-hit lymphoma." Blood.. 2017 Aug 3; 130(5):590-596. Epub 2017 Jun 09.

7/2017
Martin P, Chen Z, Cheson BD, Robinson KS, Williams M, Rajguru SA, Friedberg JW, van der Jagt RH, LaCasce AS, Joyce R, Ganjoo KN, Bartlett NL, Lemieux B, VanderWalde A, Herst J, Szer J, Bar MH, Cabanillas F, Dodds AJ, Montgomery PG, Pressnail B, Ellis T, Smith MR, Leonard JP. "Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma." British journal of haematology.. 2017 Jul 0; 178(2):250-256. Epub 2017 Apr 17.

6/1/2017
Kochenderfer JN, Somerville RPT, Lu T, Shi V, Bot A, Rossi J, Xue A, Goff SL, Yang JC, Sherry RM, Klebanoff CA, Kammula US, Sherman M, Perez A, Yuan CM, Feldman T, Friedberg JW, Roschewski MJ, Feldman SA, McIntyre L, Toomey MA, Rosenberg SA. "Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2017 Jun 1; 35(16):1803-1813. Epub 2017 Mar 14.

6/1/2017
Gopal AK, Kahl BS, Flowers CR, Martin P, Ansell SM, Abella-Dominicis E, Koh B, Ye W, Barr PM, Salles GA, Friedberg JW. "Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy." Blood.. 2017 Jun 1; 129(22):3037-3039. Epub 2017 Mar 21.

6/2017
Casulo C, Friedberg JW. "Chemotherapy free treatment of indolent lymphoma." Hematological oncology.. 2017 Jun 0; 35 Suppl 1:20-24.

5/15/2017
Reagan PM, Friedberg JW. "Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions." Oncology.. 2017 May 15; 31(5):402-11.

4/2017
Wong-Sefidan I, Byrtek M, Zhou X, Friedberg JW, Flowers CR, Zelenetz AD, Dawson KL, Reid E. "[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice." Leukemia & lymphoma.. 2017 Apr 0; 58(4):809-815. Epub 2016 Aug 12.

4/2017
Diefenbach CS, Connors JM, Friedberg JW, Leonard JP, Kahl BS, Little RF, Baizer L, Evens AM, Hoppe RT, Kelly KM, Persky DO, Younes A, Kostakaglu L, Bartlett NL. "Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations." Journal of the National Cancer Institute.. 2017 Apr 0; 109(4)Epub 2016 Dec 31.

3/20/2017
Ebert BL, Friedberg JW. "Introduction to Genomics in Hematologic Malignancy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2017 Mar 20; 35(9):927-928. Epub 2017 Feb 13.

3/2017
Chen RW, Li H, Bernstein SH, Kahwash S, Rimsza LM, Forman SJ, Constine L, Shea TC, Cashen AF, Blum KA, Fenske TS, Barr PM, Phillips T, Leblanc M, Fisher RI, Cheson BD, Smith SM, Faham M, Wilkins J, Leonard JP, Kahl BS, Friedberg JW. "RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106." British journal of haematology.. 2017 Mar 0; 176(5):759-769. Epub 2016 Dec 19.

3/2017
Hunter BD, Herr M, Meacham PJ, Barlaskar F, Evans AG, Burack WR, Liesveld JL, Becker MW, Milner LA, Constine LS, Dhakal S, Barr PM, Friedberg JW, Casulo C. "Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era." Clinical lymphoma, myeloma & leukemia.. 2017 Mar 0; 17(3):145-151. Epub 2016 Nov 23.

3/2017
Maddocks K, Barr PM, Cheson BD, Little RF, Baizer L, Kahl BS, Leonard JP, Fowler N, Gordon LI, Link BK, Friedberg JW, Ansell SM. "Recommendations for Clinical Trial Development in Follicular Lymphoma." Journal of the National Cancer Institute.. 2017 Mar 0; 109(3)Epub 2016 Dec 31.

2/2017
Danilov AV, Li H, Press OW, Shapira I, Swinnen LJ, Noy A, Reid E, Smith SM, Friedberg JW. "Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial." Leukemia & lymphoma.. 2017 Feb 0; 58(2):461-465. Epub 2016 Jul 07.

2/2017
Casulo C, O'Connor O, Shustov A, Fanale M, Friedberg JW, Leonard JP, Kahl BS, Little RF, Pinter-Brown L, Advani R, Horwitz S. "T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment." Journal of the National Cancer Institute.. 2017 Feb 0; 109(2)Epub 2016 Dec 31.

1/20/2017
Press OW, Friedberg JW. "Reply to H.J.A. Adams et al and E.A. Hawkes et al." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2017 Jan 20; 35(3):373. Epub 2016 Oct 28.

1/2017
Spurgeon SE, Till BG, Martin P, Goy AH, Dreyling MP, Gopal AK, LeBlanc M, Leonard JP, Friedberg JW, Baizer L, Little RF, Kahl BS, Smith MR. "Recommendations for Clinical Trial Development in Mantle Cell Lymphoma." Journal of the National Cancer Institute.. 2017 Jan 0; 109(1)Epub 2016 Dec 31.

12/2016
Rimsza L, Fedoriw Y, Staudt LM, Melnick A, Gascoyne R, Crump M, Baizer L, Fu K, Hsi E, Chan JW, McShane L, Leonard JP, Kahl BS, Little RF, Friedberg JW, Kostakoglu L. "General Biomarker Recommendations for Lymphoma." Journal of the National Cancer Institute.. 2016 Dec 0; 108(12)Epub 2016 Dec 16.

12/2016
Nowakowski GS, Blum KA, Kahl BS, Friedberg JW, Baizer L, Little RF, Maloney DG, Sehn LH, Williams ME, Wilson WH, Leonard JP, Smith SM. "Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research." Journal of the National Cancer Institute.. 2016 Dec 0; 108(12)Epub 2016 Dec 16.

11/2016
Reid RM, Baran A, Friedberg JW, Phillips GL, Liesveld JL, Becker MW, Wedow L, Barr PM, Milner LA. "Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective." Cancer medicine. 2016 Nov 0; 5(11):3059-3067. Epub 2016 Oct 03.

10/1/2016
Dhakal S, Bates JE, Casulo C, Friedberg JW, Becker MW, Liesveld JL, Constine LS. "Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse." International journal of radiation oncology, biology, physics.. 2016 Oct 1; 96(2):372-378. Epub 2016 May 27.

10/2016
Puvvada SD, Li H, Rimsza LM, Bernstein SH, Fisher RI, LeBlanc M, Schmelz M, Glinsmann-Gibson B, Miller TP, Maddox AM, Friedberg JW, Smith SM, Persky DO. "A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520." Leukemia & lymphoma.. 2016 Oct 0; 57(10):2359-69. Epub 2016 Jan 12.

10/2016
Ban KA, Cohen ME, Ko CY, Friedberg MW, Stulberg JJ, Zhou L, Hall BL, Hoyt DB, Bilimoria KY. "Evaluation of the ProPublica Surgeon Scorecard "Adjusted Complication Rate" Measure Specifications." Annals of surgery.. 2016 Oct 0; 264(4):566-74.

10/2016
Zhou Z, Rademaker AW, Gordon LI, LaCasce AS, Crosby-Thompson A, Vanderplas A, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson MM, Zelenetz AD, Niland J, Friedberg JW, Winter JN. "High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex." Journal of the National Comprehensive Cancer Network : JNCCN.. 2016 Oct 0; 14(10):1274-1281.

9/15/2016
Kumar A, Casulo C, Yahalom J, Schöder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH. "Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma." Blood.. 2016 Sep 15; 128(11):1458-64. Epub 2016 Jul 25.

9/1/2016
Stephens DM, Li H, LeBlanc ML, Puvvada SD, Persky D, Friedberg JW, Smith SM. "Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 Sep 1; 34(25):2997-3004. Epub 2016 Jul 05.

9/2016
Puvvada SD, Stiff PJ, Leblanc M, Cook JR, Couban S, Leonard JP, Kahl B, Marcellus D, Shea TC, Winter JN, Li H, Rimsza LM, Friedberg JW, Smith SM. "Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704." British journal of haematology.. 2016 Sep 0; 174(5):686-91. Epub 2016 Apr 13.

8/25/2016
Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, Rosenwald A, Ott G, Klapper W, Zelenetz AD, Barr PM, Friedberg JW, Ansell S, Sehn LH, Connors JM, Gascoyne RD, Hiddemann W, Unterhalt M, Weinstock DM, Weigert O. "Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy." Blood.. 2016 Aug 25; 128(8):1112-20. Epub 2016 Jul 14.

8/2016
Nabhan C, Zhou X, Day BM, Dawson K, Zelenetz AD, Friedberg JW, Cerhan JR, Link BK, Flowers CR. "Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States." American journal of hematology.. 2016 Aug 0; 91(8):770-5. Epub 2016 May 24.

6/10/2016
Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, Barr PM, Fanale MA, Knopp MV, Noy A, Hsi ED, Cook JR, Lechowicz MJ, Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher RI, Friedberg JW. "US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 Jun 10; 34(17):2020-7. Epub 2016 Apr 11.

6/2016
Reagan PM, Baran A, Kelly JL, Barr PM, Casulo C, Chengazi VU, Friedberg JW. "Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma." Clinical lymphoma, myeloma & leukemia.. 2016 Jun 0; 16(6):322-328.e2. Epub 2016 Apr 02.

5/19/2016
Barr PM, Saylors GB, Spurgeon SE, Cheson BD, Greenwald DR, O'Brien SM, Liem AK, McIntyre RE, Joshi A, Abella-Dominicis E, Hawkins MJ, Reddy A, Di Paolo J, Lee H, He J, Hu J, Dreiling LK, Friedberg JW. "Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL." Blood.. 2016 May 19; 127(20):2411-5. Epub 2016 Mar 11.

3/2016
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Zhou X, Taylor M, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR. "Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era." British journal of haematology.. 2016 Mar 0; 172(5):724-34. Epub 2016 Jan 05.

2/2016
Flinn IW, Bartlett NL, Blum KA, Ardeshna KM, LaCasce AS, Flowers CR, Shustov AR, Thress KS, Mitchell P, Zheng F, Skolnik JM, Friedberg JW. "A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)." European journal of cancer : official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR).. 2016 Feb 0; 54:11-17. Epub 2015 Dec 18.

1/2016
Till BG, Li H, Bernstein SH, Fisher RI, Burack WR, Rimsza LM, Floyd JD, DaSilva MA, Moore DF, Pozdnyakova O, Smith SM, LeBlanc M, Friedberg JW. "Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601." British journal of haematology.. 2016 Jan 0; 172(2):208-18. Epub 2015 Oct 22.

2016
Holkova B, Kmieciak M, Bose P, Yazbeck VY, Barr PM, Tombes MB, Shrader E, Weir-Wiggins C, Rollins AD, Cebula EM, Pierce E, Herr M, Sankala H, Hogan KT, Wan W, Feng C, Peterson DR, Fisher RI, Grant S, Friedberg JW. "Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas." Leukemia & lymphoma.. 2016 57(3):635-43. Epub 2015 Oct 12.

2016
Boyiadzis M, Bishop MR, Abonour R, Anderson KC, Ansell SM, Avigan D, Barbarotta L, Barrett AJ, Van Besien K, Bergsagel PL, Borrello I, Brody J, Brufsky J, Cairo M, Chari A, Cohen A, Cortes J, Forman SJ, Friedberg JW, Fuchs EJ, Gore SD, Jagannath S, Kahl BS, Kline J, Kochenderfer JN, Kwak LW, Levy R, de Lima M, Litzow MR, Mahindra A, Miller J, Munshi NC, Orlowski RZ, Pagel JM, Porter DL, Russell SJ, Schwartz K, Shipp MA, Siegel D, Stone RM, Tallman MS, Timmerman JM, Van Rhee F, Waller EK, Welsh A, Werner M, Wiernik PH, Dhodapkar MV. "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia." Journal for immunotherapy of cancer.. 2016 4:90. Epub 2016 Dec 20.

12/24/2015
Forero-Torres A, Holkova B, Goldschmidt J, Chen R, Olsen G, Boccia RV, Bordoni RE, Friedberg JW, Sharman JP, Palanca-Wessels MC, Wang Y, Yasenchak CA. "Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older." Blood.. 2015 Dec 24; 126(26):2798-804. Epub 2015 Sep 16.

11/2015
Diefenbach CS, Li H, Hong F, Gordon LI, Fisher RI, Bartlett NL, Crump M, Gascoyne RD, Wagner H, Stiff PJ, Cheson BD, Stewart DA, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ, Advani RH. "Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era." British journal of haematology.. 2015 Nov 0; 171(4):530-8. Epub 2015 Sep 07.

11/2015
Casulo C, Day B, Dawson KL, Zhou X, Flowers CR, Farber CM, Hainsworth JD, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW. "Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†." Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Nov 0; 26(11):2311-7. Epub 2015 Sep 11.

10/20/2015
Sehn LH, Goy A, Offner FC, Martinelli G, Caballero MD, Gadeberg O, Baetz T, Zelenetz AD, Gaidano G, Fayad LE, Buckstein R, Friedberg JW, Crump M, Jaksic B, Zinzani PL, Padmanabhan Iyer S, Sahin D, Chai A, Fingerle-Rowson G, Press OW. "Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Oct 20; 33(30):3467-74. Epub 2015 Aug 17.

10/2015
Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL. "Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells." British journal of haematology.. 2015 Oct 0; 171(2):205-209. Epub 2015 Jun 18.

9/2015
Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA. "Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort." American journal of hematology.. 2015 Sep 0; 90(9):778-83.

8/13/2015
Wagner-Johnston ND, Link BK, Byrtek M, Dawson KL, Hainsworth J, Flowers CR, Friedberg JW, Bartlett NL. "Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)." Blood.. 2015 Aug 13; 126(7):851-7. Epub 2015 Jun 23.

8/10/2015
Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, Hainsworth JD, Maurer MJ, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW. "Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Aug 10; 33(23):2516-22. Epub 2015 Jun 29.

7/20/2015
Barr PM, Li H, Spier C, Mahadevan D, LeBlanc M, Ul Haq M, Huber BD, Flowers CR, Wagner-Johnston ND, Horwitz SM, Fisher RI, Cheson BD, Smith SM, Kahl BS, Bartlett NL, Friedberg JW. "Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Jul 20; 33(21):2399-404. Epub 2015 Jun 15.

7/2015
Nabhan C, Byrtek M, Rai A, Dawson K, Zhou X, Link BK, Friedberg JW, Zelenetz AD, Maurer MJ, Cerhan JR, Flowers CR. "Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States." British journal of haematology.. 2015 Jul 0; 170(1):85-95. Epub 2015 Apr 07.

7/2015
Reagan PM, Friedberg JW. "Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma." Current treatment options in oncology.. 2015 Jul 0; 16(7):32.

6/20/2015
Pulvino M, Chen L, Oleksyn D, Li J, Compitello G, Rossi R, Spence S, Balakrishnan V, Jordan C, Poligone B, Casulo C, Burack R, Shapiro JL, Bernstein S, Friedberg JW, Deshaies RJ, Land H, Zhao J. "Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline." Oncotarget.. 2015 Jun 20; 6(17):14796-813.

6/10/2015
Advani RH, Hong F, Fisher RI, Bartlett NL, Robinson KS, Gascoyne RD, Wagner H, Stiff PJ, Cheson BD, Stewart DA, Gordon LI, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ. "Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Jun 10; 33(17):1936-42. Epub 2015 Apr 20.

5/7/2015
Brown JR, Barrientos JC, Barr PM, Flinn IW, Burger JA, Tran A, Clow F, James DF, Graef T, Friedberg JW, Rai K, O'Brien S. "The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia." Blood.. 2015 May 7; 125(19):2915-22. Epub 2015 Mar 09.

5/1/2015
Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, Casasnovas O, Maloney DG, Soubeyran P, Rimsza L, Haioun C, Xerri L, LeBlanc M, Tilly H, Friedberg JW. "Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 May 1; 33(13):1482-90. Epub 2015 Mar 30.

5/2015
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Taylor M, Friedberg JW, Koff JL, Link BK, Cerhan JR, Dawson KL, Flowers CR. "Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States." Leukemia & lymphoma.. 2015 May 0; 56(5):1295-302. Epub 2014 Nov 05.

4/1/2015
Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. "Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project." Cancer.. 2015 Apr 1; 121(7):1032-9. Epub 2014 Dec 09.

3/2015
Friedberg JW. "Double hit diffuse large B-cell lymphomas: diagnostic and therapeutic challenges." Chinese clinical oncology. 2015 Mar 0; 4(1):9.

2/5/2015
Mir MA, Maurer MJ, Ziesmer SC, Slager SL, Habermann T, Macon WR, Link BK, Syrbu S, Witzig T, Friedberg JW, Press O, LeBlanc M, Cerhan JR, Novak A, Ansell S. "Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma." Blood.. 2015 Feb 5; 125(6):992-8. Epub 2014 Nov 24.

2/2015
Hutchinson K, Jahangiri S, Calvi LM, Barr P, Friedberg JW, Kelly JL. "Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma." Leukemia & lymphoma.. 2015 Feb 0; 56(2):508-11. Epub 2014 Jul 15.

1/8/2015
Persky DO, Miller TP, Unger JM, Spier CM, Puvvada S, Stea BD, Press OW, Constine LS, Barton KP, Friedberg JW, LeBlanc M, Fisher RI. "Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313." Blood.. 2015 Jan 8; 125(2):236-41. Epub 2014 Nov 13.

1/1/2015
Casulo C, Burack WR, Friedberg JW. "Transformed follicular non-Hodgkin lymphoma." Blood.. 2015 Jan 1; 125(1):40-7. Epub 2014 Dec 11.

2015
Reagan PM, Friedberg JW. "Advancing radioimmunotherapy and its future role in non-Hodgkin lymphoma." Future oncology.. 2015 11(10):1543-53.

2015
Friedberg JW. "Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach." Hematology. 2015 2015:618-24.

10/1/2014
Friedberg JW. "End of rituximab maintenance for low-tumor burden follicular lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 Oct 1; 32(28):3093-5. Epub 2014 Aug 25.

10/2014
Gopal AK, Bartlett NL, Forero-Torres A, Younes A, Chen R, Friedberg JW, Matous JV, Shustov AR, Smith SE, Zain J, O'Meara MM, Fanale MA. "Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: a retrospective evaluation of safety and efficacy." Leukemia & lymphoma.. 2014 Oct 0; 55(10):2328-34. Epub 2014 Feb 24.

9/15/2014
Rahmani M, Aust MM, Benson EC, Wallace L, Friedberg J, Grant S. "PI3K/mTOR inhibition markedly potentiates HDAC inhibitor activity in NHL cells through BIM- and MCL-1-dependent mechanisms in vitro and in vivo." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2014 Sep 15; 20(18):4849-60. Epub 2014 Jul 28.

9/2014
Casulo C, Vose JM, Ho WY, Kahl B, Brunvand M, Goy A, Kasamon Y, Cheson B, Friedberg JW. "A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics." Clinical immunology : the official journal of the Clinical Immunology Society.. 2014 Sep 0; 154(1):37-46. Epub 2014 Jun 11.

9/2014
Jahangiri S, Barr P, Friedberg J. "Emerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma." Expert opinion on emerging drugs.. 2014 Sep 0; 19(3):367-83. Epub 2014 Jun 24.

8/21/2014
Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. "Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma." Blood.. 2014 Aug 21; 124(8):1259-65. Epub 2014 Jul 11.

8/2014
Friedberg JW, Unger JM, Burack WR, Gopal AK, Raju RN, Nademanee AP, Kaminski MS, Li H, Press OW, Miller TP, Fisher RI. "R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433." British journal of haematology.. 2014 Aug 0; 166(3):382-9. Epub 2014 Apr 18.

8/2014
Younes A, Thieblemont C, Morschhauser F, Flinn I, Friedberg JW, Amorim S, Hivert B, Westin J, Vermeulen J, Bandyopadhyay N, de Vries R, Balasubramanian S, Hellemans P, Smit JW, Fourneau N, Oki Y. "Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study." The Lancet. Oncology.. 2014 Aug 0; 15(9):1019-26. Epub 2014 Jul 17.

8/2014
Mbulaiteye SM, Morton LM, Sampson JN, Chang ET, Costas L, de Sanjosé S, Lightfoot T, Kelly J, Friedberg JW, Cozen W, Marcos-Gragera R, Slager SL, Birmann BM, Weisenburger DD. "Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project." Journal of the National Cancer Institute. Monographs.. 2014 Aug 0; 2014(48):106-14.

8/2014
Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN. "Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project." Journal of the National Cancer Institute. Monographs.. 2014 Aug 0; 2014(48):130-44.

7/1/2014
Herrera AF, Crosby-Thompson A, Friedberg JW, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Millenson MM, Nademanee AP, Niland JC, Rodig SJ, Rodriguez MA, Zelenetz AD, LaCasce AS. "Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network." Cancer.. 2014 Jul 1; 120(13):1993-9. Epub 2014 Apr 04.

7/1/2014
Weeks JC, Uno H, Taback N, Ting G, Cronin A, D'Amico TA, Friedberg JW, Schrag D. "Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study." Annals of internal medicine.. 2014 Jul 1; 161(1):20-30.

6/15/2014
Nastoupil LJ, Sinha R, Byrtek M, Zhou X, Taylor MD, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR. "The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States." Cancer.. 2014 Jun 15; 120(12):1830-7. Epub 2014 Mar 25.

2/6/2014
Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. "An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era." Blood.. 2014 Feb 6; 123(6):837-42. Epub 2013 Nov 21.

1/20/2014
Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, Devita VT. "Treatment of Hodgkin lymphoma: a 50-year perspective." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 Jan 20; 32(3):163-8.

1/1/2014
Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos I, Agarwal AB, Jung J, Burack R, Zhou X, Leonard EJ, Fingert H, Danaee H, Bernstein SH. "Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 Jan 1; 32(1):44-50. Epub 2013 Sep 16.

12/1/2013
Martin P, Byrtek M, Dawson K, Ziemiecki R, Friedberg JW, Cerhan JR, Flowers CR, Link BK. "Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study." Cancer.. 2013 Dec 1; 119(23):4129-36. Epub 2013 Sep 04.

12/1/2013
Press OW, Unger JM, Rimsza LM, Friedberg JW, LeBlanc M, Czuczman MS, Kaminski M, Braziel RM, Spier C, Gopal AK, Maloney DG, Cheson BD, Dakhil SR, Miller TP, Fisher RI. "A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2013 Dec 1; 19(23):6624-32. Epub 2013 Oct 15.

11/2013
Ban-Hoefen M, Vanderplas A, Crosby-Thompson AL, Abel GA, Czuczman MS, Gordon LI, Kaminski MS, Kelly J, Millenson M, Nademanee AP, Rodriguez MA, Zelenetz AD, Niland J, LaCasce AS, Friedberg JW. "Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database." British journal of haematology.. 2013 Nov 0; 163(4):487-95. Epub 2013 Sep 20.

10/31/2013
Stiff PJ, Unger JM, Cook JR, Constine LS, Couban S, Stewart DA, Shea TC, Porcu P, Winter JN, Kahl BS, Miller TP, Tubbs RR, Marcellus D, Friedberg JW, Barton KP, Mills GM, LeBlanc M, Rimsza LM, Forman SJ, Fisher RI. "Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma." The New England journal of medicine.. 2013 Oct 31; 369(18):1681-90.

10/15/2013
Evens AM, Vanderplas A, LaCasce AS, Crosby AL, Nademanee AP, Kaminski MS, Abel GA, Millenson M, Czuczman MS, Rodriguez MA, Niland J, Zelenetz AD, Gordon LI, Friedberg JW. "Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project." Cancer.. 2013 Oct 15; 119(20):3662-71. Epub 2013 Aug 06.

10/2013
Abou-Nassar KE, Vanderplas A, Friedberg JW, Abel GA, Niland J, Rodriguez MA, Czuczman MS, Millenson M, Crosby A, Gordon LI, Zelenetz AD, Kaminski M, Lacasce AS. "Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database." Leukemia & lymphoma.. 2013 Oct 0; 54(10):2155-62. Epub 2013 Feb 25.

9/2013
Reid R, Friedberg JW. "Management of marginal zone lymphoma." Oncology.. 2013 Sep 0; 27(9):840, 842, 844.

8/2013
Herman SE, Barr PM, McAuley EM, Liu D, Wiestner A, Friedberg JW. "Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia." Leukemia.. 2013 Aug 0; 27(8):1769-73. Epub 2013 Feb 06.

4/2013
Vose JM, Friedberg JW, Waller EK, Cheson BD, Juvvigunta V, Fritsch H, Petit C, Munzert G, Younes A. "The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study." Leukemia & lymphoma.. 2013 Apr 0; 54(4):708-13. Epub 2012 Oct 04.

2/20/2013
Gordon LI, Hong F, Fisher RI, Bartlett NL, Connors JM, Gascoyne RD, Wagner H, Stiff PJ, Cheson BD, Gospodarowicz M, Advani R, Kahl BS, Friedberg JW, Blum KA, Habermann TM, Tuscano JM, Hoppe RT, Horning SJ. "Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 Feb 20; 31(6):684-91. Epub 2012 Nov 26.

2/2013
Nooka AK, Nabhan C, Zhou X, Taylor MD, Byrtek M, Miller TP, Friedberg JW, Zelenetz AD, Link BK, Cerhan JR, Dillon H, Sinha R, Shenoy PJ, Levy D, Dawson K, Hirata JH, Flowers CR. "Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices." Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Feb 0; 24(2):441-8. Epub 2012 Oct 05.

2/2013
Nooka AK, Nabhan C, Zhou X, Taylor MD, Byrtek M, Miller TP, Friedberg JW, Zelenetz AD, Link BK, Cerhan JR, Dillon H, Sinha R, Shenoy PJ, Levy D, Dawson K, Hirata JH, Flowers CR. "Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices." Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Feb 0; 24(2):441-448. Epub 2019 Dec 04.

1/20/2013
Press OW, Unger JM, Rimsza LM, Friedberg JW, LeBlanc M, Czuczman MS, Kaminski M, Braziel RM, Spier C, Gopal AK, Maloney DG, Cheson BD, Dakhil SR, Miller TP, Fisher RI. "Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 Jan 20; 31(3):314-20. Epub 2012 Dec 10.

10/1/2012
Nabhan C, Byrtek M, Taylor MD, Friedberg JW, Cerhan JR, Hainsworth JD, Miller TP, Hirata J, Link BK, Flowers CR. "Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study." Cancer.. 2012 Oct 1; 118(19):4842-50. Epub 2012 Mar 20.

10/1/2012
Friedberg JW. "Double-hit diffuse large B-cell lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2012 Oct 1; 30(28):3439-43. Epub 2012 Sep 04.

9/20/2012
Friedberg JW, Byrtek M, Link BK, Flowers C, Taylor M, Hainsworth J, Cerhan JR, Zelenetz AD, Hirata J, Miller TP. "Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2012 Sep 20; 30(27):3368-75. Epub 2012 Aug 20.

6/1/2012
Kumar A, Vanderplas A, LaCasce AS, Rodriguez MA, Crosby AL, Lepisto E, Czuczman MS, Nademanee A, Niland J, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, Abel GA. "Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database." Cancer.. 2012 Jun 1; 118(11):2944-51. Epub 2011 Oct 17.

6/2012
Abel GA, Vanderplas A, Rodriguez MA, Crosby AL, Czuczman MS, Niland JC, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, LaCasce AS. "High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database." Leukemia & lymphoma.. 2012 Jun 0; 53(6):1113-6. Epub 2012 Feb 03.

6/2012
Biswas T, Culakova E, Friedberg JW, Kelly JL, Dhakal S, Liesveld J, Phillips GL, Constine LS. "Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2012 Jun 0; 103(3):367-72. Epub 2012 Mar 05.

6/2012
Friedberg JW. "Mantle cell lymphoma." Best practice & research. Clinical haematology.. 2012 Jun 0; 25(2):131-2. Epub 2012 May 17.

6/2012
Noel MS, Friedberg JW, Barr PM. "Novel agents in mantle cell lymphoma." Best practice & research. Clinical haematology.. 2012 Jun 0; 25(2):191-200. Epub 2012 Apr 30.

5/2012
Ban-Hoefen M, Kelly JL, Bernstein SH, Liesveld J, Constine L, Becker M, Milner L, Phillips G, Friedberg JW. "High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era." Leukemia & lymphoma.. 2012 May 0; 53(5):830-5. Epub 2011 Dec 06.

5/2012
Dasmahapatra G, Lembersky D, Son MP, Patel H, Peterson D, Attkisson E, Fisher RI, Friedberg JW, Dent P, Grant S. "Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC-DLBCL cells in vitro and in vivo." Molecular cancer therapeutics.. 2012 May 0; 11(5):1122-32. Epub 2012 Mar 12.

4/2012
Keller SF, Kelly JL, Sensenig E, Andreozzi J, Oliva J, Rich L, Constine L, Becker M, Phillips G, Liesveld J, Fisher RI, Bernstein SH, Friedberg JW. "Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2012 Apr 0; 18(4):640-7. Epub 2011 Aug 24.

3/1/2012
LaCasce AS, Vandergrift JL, Rodriguez MA, Abel GA, Crosby AL, Czuczman MS, Nademanee AP, Blayney DW, Gordon LI, Millenson M, Vanderplas A, Lepisto EM, Zelenetz AD, Niland J, Friedberg JW. "Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database." Blood.. 2012 Mar 1; 119(9):2093-9. Epub 2012 Jan 10.

3/2012
Barr PM, Wei C, Roger J, Schaefer-Cutillo J, Kelly JL, Rosenberg AF, Jung J, Sanz I, Friedberg JW. "Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion." Clinical immunology : the official journal of the Clinical Immunology Society.. 2012 Mar 0; 142(3):237-42. Epub 2012 Jan 05.

11/2011
Carter SJ, Bernstein SH, Friedberg JW, Barr PM. "Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma." Leukemia research.. 2011 Nov 0; 35(11):e223-4. Epub 2011 Aug 06.

10/1/2011
Friedberg JW. "New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2011 Oct 1; 17(19):6112-7. Epub 2011 Aug 15.

9/2011
Dasmahapatra G, Lembersky D, Son MP, Attkisson E, Dent P, Fisher RI, Friedberg JW, Grant S. "Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo." Molecular cancer therapeutics.. 2011 Sep 0; 10(9):1686-97. Epub 2011 Jul 12.

8/2011
Milner LA, Becker MW, Bernstein SH, Bruckner L, Friedberg JW, Holland GA, Ifthikharuddin JJ, Liesveld JL, Mathes EJ, Menchel HL, Mullen CA, Sasson T, Phillips GL. "Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease." American journal of hematology.. 2011 Aug 0; 86(8):712-4. Epub 2011 May 31.

7/2011
Phillips GL, Bernstein SH, Liesveld JL, Abboud CN, Becker MW, Constine LS, Ifthikharuddin JJ, Loughner JE, Milner LA, Vesole DH, Friedberg JW. "A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2011 Jul 0; 17(7):1033-42. Epub 2010 Nov 11.

7/2011
Barr PM, Friedberg JW. "Getting to the heart of the problem in treating diffuse large B-cell lymphoma." Leukemia & lymphoma.. 2011 Jul 0; 52(7):1166-7. Epub 2011 May 25.

7/2011
Cheson BD, Rai KR, Friedberg JW. "Accurate reporting of adverse events in chronic lymphocytic leukemia and non-Hodgkin lymphoma." Clinical advances in hematology & oncology : H&O.. 2011 Jul 0; 9(7 Suppl 15):1-11.

5/19/2011
Friedberg JW. "Hodgkin lymphoma: answers take time!" Blood.. 2011 May 19; 117(20):5274-6.

5/2011
Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. "ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II." Journal of the American College of Radiology : JACR.. 2011 May 0; 8(5):302-8.

3/10/2011
Friedberg JW, Vose JM, Kelly JL, Young F, Bernstein SH, Peterson D, Rich L, Blumel S, Proia NK, Liesveld J, Fisher RI, Armitage JO, Grant S, Leonard JP. "The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma." Blood.. 2011 Mar 10; 117(10):2807-12. Epub 2011 Jan 14.

1/13/2011
Friedberg JW. "CLL microenvironment: macro important." Blood.. 2011 Jan 13; 117(2):377-8.

1/1/2011
Friedberg JW. "Rituximab maintenance in follicular lymphoma: PRIMA." Lancet.. 2011 Jan 1; 377(9759):4-6. Epub 2010 Dec 20.

2011
Friedberg JW. "Relapsed/refractory diffuse large B-cell lymphoma." Hematology. 2011 2011:498-505.

12/2010
Cheson BD, Friedberg JW, Kahl BS, Van der Jagt RH, Tremmel L. "Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-Hodgkin lymphoma." Clinical lymphoma, myeloma & leukemia.. 2010 Dec 0; 10(6):452-7.

8/2010
Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG. "A case-control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adults." Cancer causes & control : CCC.. 2010 Aug 0; 21(8):1265-75. Epub 2010 Apr 07.

7/2010
Dougherty DW, Friedberg JW. "Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?" Current hematologic malignancy reports.. 2010 Jul 0; 5(3):148-56.

7/2010
Burack WR, Laughlin TS, Friedberg JW, Spence JM, Rothberg PG. "PCR assays detect B-lymphocyte clonality in formalin-fixed, paraffin-embedded specimens of classical hodgkin lymphoma without microdissection." American journal of clinical pathology.. 2010 Jul 0; 134(1):104-11.

5/1/2010
Biswas T, Dhakal S, Chen R, Hyrien O, Bernstein S, Friedberg JW, Fisher RI, Liesveld J, Phillips G, Constine LS. "Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era." International journal of radiation oncology, biology, physics.. 2010 May 1; 77(1):79-85. Epub 2009 Aug 03.

5/2010
Kahl BS, Cheson BD, Friedberg JW. "Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy." Clinical advances in hematology & oncology : H&O.. 2010 May 0; 8(5):1-16.

4/1/2010
Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A, Schaefer-Cutillo J, De Vos S, Sinha R, Leonard JP, Cripe LD, Gregory SA, Sterba MP, Lowe AM, Levy R, Shipp MA. "Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia." Blood.. 2010 Apr 1; 115(13):2578-85. Epub 2009 Nov 17.

1/28/2010
Friedberg JW. "PET positive, PET negative, or PET peeve?" Blood.. 2010 Jan 28; 115(4):752-3.

2010
Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ. "ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma." Current problems in cancer. 2010 34(3):211-27.

11/2009
Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG. "Vitamin D and non-Hodgkin lymphoma risk in adults: a review." Cancer investigation.. 2009 Nov 0; 27(9):942-51.

10/2009
Ban-Hoefen M, Bernstein SH, Bisognano JD, Pryor JG, Friedberg JW. "Symptomatic intracardiac diffuse large B-cell lymphoma." American journal of hematology.. 2009 Oct 0; 84(10):683-5.

9/1/2009
Dhakal S, Biswas T, Liesveld JL, Friedberg JW, Phillips GL, Constine LS. "Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma." International journal of radiation oncology, biology, physics.. 2009 Sep 1; 75(1):188-92. Epub 2009 Feb 26.

9/2009
Friedberg JW. "Bendamustine in chronic lymphocytic leukemia: the future is combination therapy." Leukemia & lymphoma.. 2009 Sep 0; 50(9):1399-400.

8/2009
Friedberg JW, Kelly JL, Neuberg D, Peterson DR, Kutok JL, Salloum R, Brenn T, Fisher DC, Ronan E, Dalton V, Rich L, Marquis D, Sims P, Rothberg PG, Liesveld J, Fisher RI, Coffman R, Mosmann T, Freedman AS. "Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma." British journal of haematology.. 2009 Aug 0; 146(3):282-91. Epub 2009 Jun 10.

8/2009
Kelly JL, Toothaker SR, Ciminello L, Hoelzer D, Holte H, LaCasce AS, Mead G, Thomas D, Van Imhoff GW, Kahl BS, Cheson BD, Magrath IT, Fisher RI, Friedberg JW. "Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens." Clinical lymphoma & myeloma. 2009 Aug 0; 9(4):307-10.

6/2009
Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P, Joyce R, Takvorian RW, Fisher DC, Fisher RI, Liesveld J, Marquis D, Neuberg D, Freedman AS. "A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas." British journal of haematology.. 2009 Jun 0; 145(6):741-8. Epub 2009 Mar 30.

6/2009
Sud R, Friedberg JW. "Relapsed/refractory diffuse large B-cell lymphoma: on the threshold of new therapies." Oncology.. 2009 Jun 0; 23(7):615-6, 619.

4/16/2009
Hilchey SP, Hyrien O, Mosmann TR, Livingstone AM, Friedberg JW, Young F, Fisher RI, Kelleher RJ, Bankert RB, Bernstein SH. "Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab." Blood.. 2009 Apr 16; 113(16):3809-12. Epub 2009 Feb 04.

4/2009
Mendler JH, Friedberg JW. "Salvage therapy in Hodgkin's lymphoma." The oncologist.. 2009 Apr 0; 14(4):425-32. Epub 2009 Apr 02.

3/10/2009
Friedberg JW, Taylor MD, Cerhan JR, Flowers CR, Dillon H, Farber CM, Rogers ES, Hainsworth JD, Wong EK, Vose JM, Zelenetz AD, Link BK. "Follicular lymphoma in the United States: first report of the national LymphoCare study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2009 Mar 10; 27(8):1202-8. Epub 2009 Feb 09.

3/2009
Friedberg JW. "The emerging role of bendamustine in follicular lymphoma." Leukemia & lymphoma.. 2009 Mar 0; 50(3):317-8.

2/2009
McLaughlin P, Friedberg JW. "Seeking wisdom from the Seer." Leukemia & lymphoma.. 2009 Feb 0; 50(2):145-7.

2009
Toothaker SR, Kelly J, Ciminello L, Hoelzer D, Holte H, LaCasce AS, Mead , Thomas D, van Imhoff GW, Kahl BS, Cheson BD, Magrath IT, Fisher RI, Friedberg JW. "Outcomes of patients with Burkitt lymphoma older than age 40 treated with aggressive chemotherapeutic regimens" . Clinical Lymphoma and Myeloma. 2009; in press.

12/1/2008
Kho ME, Lepisto EM, Niland JC, Friedberg JW, Lacasce AS, Weeks JC. "Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multicenter outcomes database." Cancer.. 2008 Dec 1; 113(11):3209-12.

12/2008
Sud R, Friedberg JW. "Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab." Haematologica.. 2008 Dec 0; 93(12):1776-80.

11/1/2008
LaCasce AS, Kho ME, Friedberg JW, Niland JC, Abel GA, Rodriguez MA, Czuczman MS, Millenson MM, Zelenetz AD, Weeks JC. "Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2008 Nov 1; 26(31):5107-12. Epub 2008 Sep 02.

10/2008
Mendler JH, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW. "Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology. 2008 Oct 0; 19(10):1759-64. Epub 2008 May 25.

10/2008
Friedberg JW, Fisher RI. "Diffuse large B-cell lymphoma." Hematology/oncology clinics of North America.. 2008 Oct 0; 22(5):941-52, ix.

10/2008
Sikder MA, Friedberg JW. "Beyond rituximab: The future of monoclonal antibodies in B-cell non-Hodgkin lymphoma." Current hematologic malignancy reports.. 2008 Oct 0; 3(4):187-93.

9/2008
Sikder MA, Friedberg JW. "Beyond rituximab: the future of monoclonal antibodies in B-cell non-Hodgkin lymphoma." Current oncology reports.. 2008 Sep 0; 10(5):420-6.

7/2008
Friedberg JW. "Treatment of follicular non-Hodgkin's lymphoma: the old and the new." Seminars in hematology.. 2008 Jul 0; 45(3 Suppl 2):S2-6.

6/1/2008
Friedberg JW. "Bak to death with chemotherapy." Blood.. 2008 Jun 1; 111(11):5263-4.

5/2008
Walker AR, Kleiner A, Rich L, Conners C, Fisher RI, Anolik J, Friedberg JW. "Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma." Cancer investigation.. 2008 May 0; 26(4):431-3.

4/2008
Link BK, Friedberg JW. "Monoclonal antibodies in lymphoma: the first decade." Seminars in hematology.. 2008 Apr 0; 45(2):71-4.

4/2008
Schaefer-Cutillo J, Friedberg JW. "Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphoma." Seminars in hematology.. 2008 Apr 0; 45(2):110-7.

3/2008
Friedberg JW. "Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma." Haematologica.. 2008 Mar 0; 93(3):336-8.

1/10/2008
Friedberg JW, Cohen P, Chen L, Robinson KS, Forero-Torres A, La Casce AS, Fayad LE, Bessudo A, Camacho ES, Williams ME, van der Jagt RH, Oliver JW, Cheson BD. "Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2008 Jan 10; 26(2):204-10.

2008
Friedberg JW, Cohen P, Chen L, Robinson K, Forero-Torres A, LaCasce A, Fayad L, Bessudo A, Camacho E, Williams M, van der Jagt R, Oliver J, Loh E, Cheson BD:. "Bendamustine in patients with rituximab-refractory and alkylator-refractory, indolent non-Hodgkin's lymphoma: results from a phase I multicenter, single-agent study." Jounal of Clinical Oncology. 2008; 26: 204-10.

2008
Friedberg JW, Jacobsen E, Neuberg D, Kutok J, Munoz O, Boussiotis V, Reynolds H, Fisher DC, Szot A, Van den Abbeele AD, Freedman AS. "Targeting the follicular lymphoma microenvironment through blockade of TNF-alpha with etanercept." Leukemia and Lymphoma. 2008; 49: 902-09.

2008
Walker AR, Kleiner A, Rich L, Conners C, Fisher RI, Anolik J, Friedberg JW. "Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma." Cancer Investigation. 2008; 26: 431-3.

2008
Mendler J, Kelly J, Voci S, Marquis D, Rich L, Rossi RM, Bernstein SH, Jordan CT, Liesveld J, Fisher RI, Friedberg JW. "Bortezomib and gemcitabine in relapsed or refractory Hodgkin lymphoma." Annual Oncology. 2008; 19: 1759-64.

2008
LaCasce AS, Kho ME, Friedberg JW, Niland J, Abel G, Rodriguez MA, Czuczman M, Millenson M, Weeks J. "Comparison of Referring and Final Pathology for Non-Hodgkin's Lymphoma Patients in the National Comprehensive Cancer Network (NCCN)" . Journal of Clinical Oncology. 2008; 26: 5107-12.

2008
Kho ME, Lepisto E, Niland JC, Friedberg JW, LaCasce AS, Weeks JC. "Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multi-institutional outcomes database." Cancer. 2008; 113: 3209-12.

2008
Bernstein SH, Unger J, LeBlanc M, Friedberg JW, Miller T, Fisher RI. "CNS events in patients with aggressive non Hodgkin's lymphoma: the role of CNS prophylaxis." Journal of Clinical Oncology. 2008; in press.

2008
Walker A, Komrokji R, Ifthikharuddin J, Messina P, Mulford D, Becker M, Friedberg JW, Oliva J, Phillips G, Liesveld J, Abboud CA. "Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML." Leukemia Research. 2008; 32: 1830-6.

2008
Friedberg JW, Taylor MD, Cerhan JR, Flowers C, Dillon H, Farber CM, Rogers E, Hainsworth J, Wong EK, Vose JM, Zelenetz AD, Link BK. "Follicular lymphoma in the United States: First report of the National LymphoCare Study." Journal of Clinical Oncology. 2008; : in press.

2008
Ban-Hoefen M, Bernstein S, Bisognano JD, Pryor JG, Friedberg JW. "Symptomatic Intracardiac Diffuse large B-cell lymphoma" . American Journal of Hematology. 2008; : in press.

2008
Dhakal S, Biswas T, Liesveld J, Friedberg JW, Phillips G, Constine LS. "Patterns and Timing of initial relapse in patients transplanted for Hodgkin lymphoma." International Journal of Radiation Oncology,Biology,Physics. 2008; in press.

2008
Perkins AS, Friedberg JW. "Burkitt lymphoma in adults." Hematology. 2008 :341-8.

8/2007
Leonard JP, Friedberg JW, Hagemeister FB, Levine AM. "Combination treatment approaches and novel therapies for lymphoma." Clinical advances in hematology & oncology : H&O.. 2007 Aug 0; 5(8 Suppl 12):4-20; quiz 1 p following 20.

7/2007
Leonard JP, Friedberg JW, Younes A, Fisher D, Gordon LI, Moore J, Czuczman M, Miller T, Stiff P, Cheson BD, Forero-Torres A, Chieffo N, McKinney B, Finucane D, Molina A. "A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma." Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Jul 0; 18(7):1216-23. Epub 2007 Apr 29.

6/2007
Bartlett NL, Niedzwiecki D, Johnson JL, Friedberg JW, Johnson KB, van Besien K, Zelenetz AD, Cheson BD, Canellos GP, . "Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804." Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Jun 0; 18(6):1071-9. Epub 2007 Apr 10.

2/2007
Anolik JH, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner EC, Fisher RI, Sanz I. "B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny." Clinical immunology : the official journal of the Clinical Immunology Society.. 2007 Feb 0; 122(2):139-45. Epub 2006 Sep 27.

2/2007
Schaefer-Cutillo J, Friedberg JW, Fisher RI. "Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma." Oncology.. 2007 Feb 0; 21(2):203-12; discussion 214, 217, 221.

2007
Anolik J, Friedberg JW, Zheng B, Barnard J, Owen T, Cushing E, Kelly J, Milner ECB, Fisher RI, Sanz I. "B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny." Clinical Immunology. 2007; 122: 139-45.

2007
Leonard JP, Friedberg JW*, Younes A, Fisher D, Gordon LI, Moore J, Czuczman M, Miller T, Stiff P, Cheson BD, Forero-Torres A, Chieffo N, McKinney B, Finucane D, Molina A. "A Phase I/II study of galiximab in combination with rituximab for relapsed or refractory follicular lymphoma" . Annual Oncology. 2007; 18: 1216-23.

2007
Bartlett, NL, Niedzwiecki, D, Johnson, JL, Friedberg, JW, Johnson KB, van Besien K, Zelenetz AD, Cheson, BD, Canellos GP. "Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma" . Annual Oncology. 2007; 18: 1071-9.

11/2006
Friedberg JW. "Potential long-term toxicities should influence the choice of therapy for indolent non-Hodgkin's lymphoma." Haematologica.. 2006 Nov 0; 91(11):1453-5.

7/2006
Friedberg JW, Freedman AS. "Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphoma." Current treatment options in oncology.. 2006 Jul 0; 7(4):276-84.

5/2006
Vargas RL, Fallone E, Felgar RE, Friedberg JW, Arbini AA, Andersen AA, Rothberg PG. "Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience." Leukemia research.. 2006 May 0; 30(5):547-51. Epub 2005 Oct 24.

5/2006
Friedberg JW. "Rituximab for early-stage diffuse large-B-cell lymphoma." The Lancet. Oncology.. 2006 May 0; 7(5):357-9.

2006
Friedberg JW, Fisher RI. "Diffuse large B-cell NHL." Cancer treatment and research.. 2006 131:121-40.

4/1/2005
Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS. "Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2005 Apr 1; 23(10):2208-14. Epub 2005 Mar 07.

1/15/2005
Friedberg JW, Kim H, McCauley M, Hessel EM, Sims P, Fisher DC, Nadler LM, Coffman RL, Freedman AS. "Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity." Blood.. 2005 Jan 15; 105(2):489-95. Epub 2004 Sep 09.

2005
Fisher RI, Friedberg JW. "Update on mantle cell lymphoma and diffuse large B-cell non-Hodgkin's lymphoma." Lymphoma Annual Update 2005; Clinical Care Options. 2005; .

2005
Friedberg JW. "Unique toxicities and resistance mechanisms associated with monoclonal antibody therapy." Hematology. 2005 :329-34.

12/1/2004
Friedberg JW. "Radioimmunotherapy for non-Hodgkin's lymphoma." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2004 Dec 1; 10(23):7789-91.

12/2004
Phillips GL, Abboud CN, Bernstein SH, Friedberg JW, Ifthikharuddin JJ, Lancet JE, Liesveld JL, Spreng E, Johnson V, Chapman M, Vesole DH. "Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report." Seminars in oncology.. 2004 Dec 0; 31(6 Suppl 18):59-61.

11/1/2004
Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI. "Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2004 Nov 1; 22(21):4302-11. Epub 2004 Sep 20.

8/15/2004
Friedberg JW. "Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab era." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2004 Aug 15; 10(16):5297-8.

2/2004
Friedberg JW, Dong DA, Li S, Kim H, Stephans K, Noonan K, Neuberg D, Gribben JG, Fisher DC, Freedman AS, Takvorian T, Jurgens R, Battle TE, Frank DA. "Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo." Leukemia research.. 2004 Feb 0; 28(2):139-47.

2/2004
Friedberg JW, Fisher RI. "Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma." Expert review of anticancer therapy.. 2004 Feb 0; 4(1):18-26.

2/2004
Brown JR, Gaudet G, Friedberg JW, Neuberg D, Mauch P, Kutok JL, Takvorian T, Fisher DC, Gribben JG, Kim H, Nadler LM, Freedman AS. "Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma." Leukemia & lymphoma.. 2004 Feb 0; 45(2):315-20.

1/2004
Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. "FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison." Leukemia & lymphoma.. 2004 Jan 0; 45(1):85-92.

2004
Friedberg JW, Fisher RI. "Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma." Expert Rev Anticancer Therapy. 2004; 4: 18-26.

10/2003
Friedberg JW, Kim H, Li S, Neuberg D, Boyd K, Daley H, Fisher DC, Gribben JG, Spitzer T, Freedman AS. "Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-Hodgkin's lymphoma." Bone marrow transplantation.. 2003 Oct 0; 32(7):681-6.

9/1/2003
Friedberg JW, Neuberg D, Kim H, Miyata S, McCauley M, Fisher DC, Takvorian T, Canellos GP. "Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity." Cancer.. 2003 Sep 1; 98(5):978-82.

2003
Friedberg JW, Aster J, and Canellos GP.;. "Hodgkin's Disease". Blood: Principles and Practice of Hematalogy. 2003; .

2003
Friedberg JW, Chengazi V. "PET scans in the staging of lymphoma: current status." The oncologist.. 2003 8(5):438-47.

9/15/2002
Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, Tarbell NJ, Stevenson MA, Friedberg JW, Mauch PM. "Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors." Blood.. 2002 Sep 15; 100(6):1989-96.

6/2002
Friedberg JW, Neuberg D, Gribben JG, Fisher DC, Canning C, Koval M, Poor CM, Green LM, Daley J, Soiffer R, Ritz J, Freedman AS. "Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma." British journal of haematology.. 2002 Jun 0; 117(4):828-34.

4/15/2002
Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, Tarbell NJ, Friedberg J, Canellos GP, Mauch PM. "Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2002 Apr 15; 20(8):2101-8.

1/2002
Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. "Breast lymphoma associated with breast implants: two case-reports and a review of the literature." Leukemia & lymphoma.. 2002 Jan 0; 43(1):115-9.

2002
Friedberg JW and DiPiro PJ;. "Staging and pretreatment evaluation of Hodgkin's disease." Atlas of Clinical Oncology, Malignant lymphomas, Malignant Grossbard. 2002; .

2002
Webb IJ, Friedberg W, Gribben JG, Fisher DC, Spitzer T, Neuberg D, Jallow H, Kim H, Houde H, Monroy R, Schmittling R, Freedman AS. "Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2002 8(8):429-34.

2002
Alyea EP, Weller E, Fisher DC, Freedman AS, Gribben JG, Lee S, Schlossman RL, Stone RM, Friedberg J, DeAngelo D, Liney D, Windawi S, Ng A, Mauch P, Antin JH, Soiffer RJ. "Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2002 8(11):601-7.

2001
Friedberg JW, Neuberg D, Monson E, Jallow H, Nadler LM, Freedman AS. "The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2001 7(8):446-53.

3/2000
Freedman A, Friedberg JW, Gribben J. "High-dose therapy for follicular lymphoma." Oncology.. 2000 Mar 0; 14(3):321-6, 329; discussion 330-2, 338.

10/15/1999
Friedberg JW, Van den Abbeele AD, Kehoe K, Singer S, Fletcher CD, Demetri GD. "Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma." Cancer.. 1999 Oct 15; 86(8):1621-7.

10/1999
Friedberg JW, Neuberg D, Stone RM, Alyea E, Jallow H, LaCasce A, Mauch PM, Gribben JG, Ritz J, Nadler LM, Soiffer RJ, Freedman AS. "Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 1999 Oct 0; 17(10):3128-35.

5/1999
Friedberg JW, Freedman AS. "High-dose therapy and stem cell transplantation in follicular lymphoma." Annals of hematology.. 1999 May 0; 78(5):203-11.

1999
Friedberg JW, Neuberg D, Gribben JG, Mauch P, Anderson KC, Soiffer RJ, Takvorian T, Fisher DC, Schlossman R, Jallow H, Kuhlman C, Ritz J, Freedman AS. "Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 1999 5(4):262-8.

1998
Viguera AC, Baldessarini RJ, Friedberg J. "Discontinuing antidepressant treatment in major depression." Harvard review of psychiatry.. 1998 5(6):293-306.

7/15/1997
Rosand J, Friedberg JW, Yang JM. "Fatal phenformin-associated lactic acidosis." Annals of internal medicine.. 1997 Jul 15; 127(2):170.

6/1995
Friedberg JW, Frankenburg FR, Burk J, Johnson W. "Clozapine-caused eosinophilic colitis." Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.. 1995 Jun 0; 7(2):97-8.

12/1993
Banov MD, Tohen M, Friedberg J. "High risk of eosinophilia in women treated with clozapine." The Journal of clinical psychiatry.. 1993 Dec 0; 54(12):466-9.

9/1992
Friedberg JW. "From municipal hospital to medical center: Milwaukee County General Hospital, 1965-1980." Wisconsin medical journal.. 1992 Sep 0; 91(9):547-9.

Friedberg JW, Ng A;. "Epidemiology of second malignancies following lymphoma therapy and screening recommendations." In Press.

Friedberg JW, Freedman AS. "Antibody and immunomodulatory agents in treatment of indolent NHL." In Press. .

Books & Chapters

2008
Chapter Title: Lymphocyte-predominant Hodgkin's lymphoma. Evidence-based Hematology
Book Title: Evidence-based Hematology
Author List: McMahon B, Friedberg JW
Published By: Evidence based Hematology2008

2008
Chapter Title: Monoclonal antibodies in lymphoma: the first decade.
Book Title: Seminars in Hematology
Author List: Link BK and Friedberg JW
Published By: Seminars in Hematology2008

2008
Chapter Title: Non-myeloablative radioimmunotherapy for lymphoma.
Book Title: Seminars in Hematology
Author List: Schaefer-Cutillo J., Friedberg JW
Published By: Seminars in Hematology2008

2008
Chapter Title: Beyond rituximab: the future of monoclonal antibody in B-cell non-Hodgkin's lymphoma.
Book Title: Current Oncology Reports
Author List: Sikder M, Friedberg JW:
Published By: Current Oncology Reports2008

2008
Chapter Title: : Non-Hodgkin's lymphomas
Book Title: Cancer, Principles & Practice of Oncology 8th edition
Author List: Friedberg JW, Mauch PM, Rimsza LM, Fisher RI
Published By: Lippincott Williams & Wilkins2008

2008
Chapter Title: Treatment of follicular non-Hodgkin's lymphoma: the old and the new.
Book Title: Seminars in Hematology
Author List: Friedberg JW
Published By: Seminars in Hematology2008

2008
Chapter Title: Diffuse Large B cell lymphoma
Book Title: Hematology/Oncology Clinics of North America
Author List: Friedberg JW, Fisher RI
Published By: Hematology/Oncology Clinics of North America2008

2007
Chapter Title: Novel Concepts in Radioimmunotherapy for Non-Hodgkin's Lymphoma
Book Title: Oncology
Author List: Schaefer-Cutillo J, Friedberg JW, Fisher RI
Published By: Oncology2007

2007
Chapter Title: Role of Bortezomib in the treatment of lymphoma.
Book Title: Cancer Investigation
Author List: Barr P, Fisher RI, Friedberg JW
Published By: Cancer Investigation2007

2007
Chapter Title: Combination treatment approaches and novel therapies for lymphoma.
Book Title: Clinical Advancements in Hematology and Oncology 5
Author List: Leonard JP, Friedberg JW, Hagameister FB, Levine AM
Published By: Clinical Advancements in Hematology and Oncology 52007

2006
Chapter Title: Epidemiology of second malignancies following lymphoma therapy and screening recommendations.
Book Title: Clinical Malignant Hematology
Author List: Friedberg JW, Ng, A
Edited By: Sekeres, MA
Published By: McGraw-Hill2006

2006
Chapter Title: "Diffuse Large B-cell Lymphoma"
Book Title: Hodgkin and non-Hodgkin lymphoma
Author List: Friedberg JW, Fisher RI
Edited By: Leonard JP, Coleman M, editors.
Published By: Springer, NY, USA,2006

2006
Chapter Title: Antibody and immunomodulatory agents in treatment of indolent NHL.
Book Title: Current Treatment Options Oncology
Author List: Friedberg JW, Freedman AS
Published By: Current Treatment options Oncology2006

2006
Chapter Title: Diffuse Large B Cell NHL
Book Title: Cancer Treatment Research
Author List: Friedberg JW, Fisher RI
Published By: Cancer Treatment Research2006

2006
Chapter Title: Pst-Transplant Lympoproliferative Disease
Book Title: The Lymphomas
Author List: Friedberg JW, Swinnen LJ
Edited By: Canellos GP, Lister TA, Young BD
Published By: Elsevier2006

2006
Chapter Title: Large-cell lymphoma, nodal, splenic
Book Title: The Lymphomas
Author List: Friedberg JW, Fisher RI
Edited By: Canellos GP, Lister TA, Young BD
Published By: Elsvier2006

2006
Chapter Title: Hodgkin lymphoma, Diagnosis
Book Title: The Lymphomas
Author List: Friedberg JW
Edited By: Canellos GP, Lister TA, Young BD
Published By: Elsvier2006

2005
Chapter Title: Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy.
Book Title: Hematology 2005
Author List: Friedberg JW
Published By: American Society of Hematology Education Program Book2005

2005
Chapter Title: Update on mantle cell lymphoma and diffuse large B-cell non-Hodgkin's lymphoma.
Book Title: Lymphoma Annual Update 2005
Author List: Fisher RI, Friedberg JW
Published By: at http://clinicaloptions.com/lymphoma20052005

2005
Chapter Title: Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy.
Book Title: American Society of Hematology Education
Author List: Friedberg JW
Published By: American Society of Hematology Education Program Book2005

2005
Chapter Title: Non-Hodgkin's Lymphoma
Book Title: Cancer, Principles & Practice of Oncology
Author List: Fisher RI, Mauch PM, Harris NL, Friedberg JW
Edited By: Devita Jr VT, Hellman S, Rosenberg SA
Published By: Lippincott Williams & Wilkins2005 in Philadelphia, PA

2004
Chapter Title: Follicular lymphoma
Book Title: Non-Hodgkin's Lymphoma
Author List: Freedman AS, Friedberg JW
Published By: Lippincott, Williams and Wilkins2004 in Philadelphia, PA

2003
Chapter Title: Hodgkin's Disease
Book Title: Blood: Principles and Practice of Hematology
Author List: Friedberg JW, Aster J, and Canellos GP
Published By: Lippincott, Williams and Wilkins2003 in Philadelphia, PA

2003
Chapter Title: Myelodysplasia after autologous stem cell transplantation.
Book Title: Clinical Bone Marrow and Stem Cell Transplantation
Author List: Friedberg JW
Published By: Cambridge University Press2003

2003
Chapter Title: Cancer and the Immunocompromised Host.
Book Title: Clinical Practice of Hematology and Oncology
Author List: Scadden DT and Friedberg JW
Edited By: Furie B, Cassileth P, Atkins M and Mayer RJ
Published By: WB Saunders Company2003 in Philadelphia, PA

2002
Chapter Title: Staging and pretreatment evaluation of Hodgkin's disease.
Book Title: Atlas of Clinical Oncology, Malignant lymphomas, ML Grossband
Author List: Friedberg JW and Dipiro PJ
Published By: B C Decker Inc.2002 in Hamilton, London